Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nuwellis, Inc. (NUWE)
:NUWE
Holding NUWE?
Track your performance easily
Earnings Data
Report Date
Mar 04, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.43Last Year’s EPS
-78.4Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 06, 2018
|% Change Since: -40.33%
|Next Earnings Date:Aug 07, 2018
Earnings Call Sentiment|Neutral
The earnings call reflected both positive and negative aspects. While there were significant improvements in pediatric revenue, gross margin, and net income, and a notable upcoming CMS reimbursement increase, there were also declines in overall revenue and critical care and heart failure segments. The reduction in R&D expenses also highlights potential limitations in future innovation.Company Guidance
During the Nuwellis Q3 2024 earnings call, the company provided several key financial and operational metrics. Nuwellis reported a revenue of $2.4 million, marking an 8% sequential growth but a 2% decline year-over-year. The pediatric customer category surged by 28% due to the addition of three new pediatric centers, while the critical care and heart failure categories saw declines of 25% and 36%, respectively. Gross margin improved to 70%, up from 57.3% in the prior year, driven by higher manufacturing volumes and lower fixed overhead expenses. Operating expenses decreased by 30% to $3.2 million, leading to an operating loss of $1.5 million, a significant improvement from the $3.2 million loss in the previous year. The company also reported a net income of $2.4 million, or $1.74 per share, primarily due to the revaluation of a prior period warrant liability. Nuwellis ended the quarter with $1.9 million in cash and no debt, supported by recent funding efforts totaling $2.9 million in gross proceeds. The company anticipates accelerated growth with a nearly 300% increase in outpatient reimbursement rates for its Aquadex therapy, effective January 1, 2025.Pediatric Revenue Surge
The pediatric customer category experienced a 28% revenue increase compared to the same quarter last year, driven by three new pediatric accounts, including one of the largest hospital networks in Florida.
Gross Margin Improvement
Gross margin improved to 70% in the third quarter, up from 57.3% in the prior year quarter, primarily due to higher manufacturing volumes of consumables and lower fixed overhead manufacturing expenses.
Operating Loss Reduction
Operating loss in the third quarter was $1.5 million, compared to an operating loss of $3.2 million in the prior year period, resulting in a $1.7 million improvement.
Net Income Improvement
Net income attributable to common shareholders in the third quarter was $2.4 million, or a gain of $1.74 per share, compared to a net loss of $3.4 million or a loss of $63.27 per share for the same period in 2023.
CMS Reimbursement Increase
Effective January 1, 2025, the facility reimbursement fee for Aquadex ultrafiltration will increase 297%, from $413 to $1,639 per day, reflecting a significant reimbursement improvement.
---
NUWE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NUWE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 11, 2024 | $1.81 | $2.05 | +13.26% |
| Aug 13, 2024 | $2.65 | $2.14 | -19.25% |
| May 07, 2024 | $5.98 | $9.22 | +54.18% |
| Mar 05, 2024 | $20.86 | $17.36 | -16.78% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Nuwellis, Inc. (NUWE) report earnings?
Nuwellis, Inc. (NUWE) is schdueled to report earning on Mar 04, 2025, TBA Not Confirmed.
What is Nuwellis, Inc. (NUWE) earnings time?
Nuwellis, Inc. (NUWE) earnings time is at Mar 04, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NUWE EPS forecast?
NUWE EPS forecast for the fiscal quarter 2024 (Q4) is -0.43.
---